CAPTRUST Financial Advisors
RVMD icon

CAPTRUST Financial Advisors’s Revolution Medicines RVMD Stock Holding History

CAPTRUST Financial Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.05M Buy
16,289
+5,851
+56% +$855K ﹤0.01% 1071
2026
Q1 		$1.02M Sell
10,438
-31
-0.3% -$3.13K ﹤0.01% 1609
2025
Q4 		$834K Sell
10,469
-621
-6% -$40.7K ﹤0.01% 1608
2025
Q3 		$518K Sell
11,090
-71
-0.6% -$2.78K ﹤0.01% 1794
2025
Q2 		$411K Buy
11,161
+2,946
+36% +$113K ﹤0.01% 1855
2025
Q1 		$290K Sell
8,215
-318
-4% -$12.9K ﹤0.01% 1962
2024
Q4 		$373K Buy
8,533
+74
+0.9% +$3.73K ﹤0.01% 1777
2024
Q3 		$384K Buy
8,459
+337
+4% +$14.7K ﹤0.01% 1741
2024
Q2 		$315K Buy
8,122
+22
+0.3% +$822 ﹤0.01% 1787
2024
Q1 		$261K Buy
+8,100
New +$240K ﹤0.01% 1853

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

CAPTRUST Financial Advisors's RVMD Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its Revolution Medicines (RVMD) stake by 56% in Q2 2026, buying an estimated $855K and bringing the position to 16,289 shares worth $3.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1071.

CAPTRUST Financial Advisors first reported a position in RVMD in Q1 2024 and has held it in 10 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • CAPTRUST Financial Advisors held 16,289 shares of Revolution Medicines worth $3.05M as of Q2 2026.
  • CAPTRUST Financial Advisors bought 5,851 Revolution Medicines shares in Q2 2026, an estimated $855K.
  • Revolution Medicines made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #1071 holding.
  • CAPTRUST Financial Advisors first reported a position in Revolution Medicines in Q1 2024 and has held it in 10 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.